The Nose as a Route for Therapy: Part 1. Pharmacotherapy
暂无分享,去创建一个
N. Papadopoulos | G. Scadding | L. Klimek | C. Cingi | N. Bayar Muluk | S. Toppila-Salmi | M. Hytönen | A. Laulajainen-Hongisto | D. Mitsias | Dimitrios I Mitsias
[1] C. Bachert,et al. Correction to: Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper , 2020, Clinical and Translational Allergy.
[2] P. Kauppi,et al. High discontinuation rates of peroral ASA treatment for CRSwNP. A real-world multi-center study of 171 N-ERD patients. , 2020, The journal of allergy and clinical immunology. In practice.
[3] J. Mullol,et al. Common Cold and Acute Rhinosinusitis: Up-to-Date Management in 2020 , 2020, Current Allergy and Asthma Reports.
[4] W. Fokkens,et al. Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps. , 2020, Rhinology.
[5] M. Mantero,et al. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry. , 2020, Respiratory medicine.
[6] W. Fokkens,et al. Executive summary of EPOS 2020 including integrated care pathways. , 2020, Rhinology.
[7] J. Bousquet,et al. Effect of nasal irrigation on allergic rhinitis control in children; complementarity between CARAT and MASK outcomes , 2020, Clinical and Translational Allergy.
[8] D. Wang,et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. , 2020, Rhinology.
[9] S. Loukides,et al. Severe Eosinophilic Asthma , 2019, Journal of clinical medicine.
[10] R. de Caterina,et al. The first 3500 years of aspirin history from its roots - A concise summary. , 2019, Vascular pharmacology.
[11] Chien-Yu Lin,et al. Effectiveness of Hypertonic Saline Nasal Irrigation for Alleviating Allergic Rhinitis in Children: A Systematic Review and Meta-Analysis , 2019, Journal of clinical medicine.
[12] Andrew A. White,et al. Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper , 2018, Allergy.
[13] O. Niemelä,et al. Prevalence of Patients Eligible for Anti-IL-5 Treatment in a Cohort of Adult-Onset Asthma. , 2019, The journal of allergy and clinical immunology. In practice.
[14] G. Canonica,et al. Adherence to treatment in allergic respiratory diseases , 2018, Expert review of respiratory medicine.
[15] J. Perkins,et al. NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs , 2018, Scientific Reports.
[16] A. Dublin,et al. Anatomy, Head and Neck, Nose Paranasal Sinuses , 2018 .
[17] F. Carinci,et al. Saline nasal irrigations for chronic rhinosinusitis: From everyday practice to evidence-based medicine. An update , 2018, International journal of immunopathology and pharmacology.
[18] Andrew A. White,et al. Aspirin-Exacerbated Respiratory Disease. , 2018, The New England journal of medicine.
[19] S. Feng,et al. The effects of nasal irrigation with various solutions after endoscopic sinus surgery: systematic review and meta-analysis. , 2018, The Journal of laryngology and otology.
[20] E. Sapmaz,et al. A new classification for septal perforation and effects of treatment methods on quality of life , 2018, Brazilian journal of otorhinolaryngology.
[21] R. Harvey,et al. Characteristics of macrolide responders in persistent post-surgical rhinosinusitis. , 2018, Rhinology.
[22] K. Snidvongs,et al. Hypertonic Saline Versus Isotonic Saline Nasal Irrigation: Systematic Review and Meta-analysis , 2018, American journal of rhinology & allergy.
[23] J. Palmer,et al. Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin‐exacerbated respiratory disease , 2018, International forum of allergy & rhinology.
[24] H. Kitagawa,et al. Immunohistochemical study on the secretory host defense system with lysozyme and secretory phospholipase A2 throughout rat respiratory tract , 2017, The Journal of veterinary medical science.
[25] G. Scadding,et al. Saline irrigation for allergic rhinitis. , 2017, The Cochrane database of systematic reviews.
[26] Lysine acetylsalicylate , 2018, Reactions Weekly.
[27] R. Simon,et al. Safety and outcomes of aspirin desensitization for aspirin‐exacerbated respiratory disease: A single‐center study , 2018, The Journal of allergy and clinical immunology.
[28] H. Esmaeilzadeh,et al. Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease , 2017, Iranian journal of pharmaceutical research : IJPR.
[29] A. Romano,et al. Aspirin challenge and desensitization: how, when and why , 2017, Current opinion in allergy and clinical immunology.
[30] S. Durham,et al. BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis (Revised Edition 2017; First edition 2007) , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[31] A. Peters,et al. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease. , 2017, The journal of allergy and clinical immunology. In practice.
[32] L. Rudmik,et al. Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis , 2017, The Laryngoscope.
[33] B. Tajudeen,et al. The role of aspirin desensitization in the management of aspirin-exacerbated respiratory disease , 2016, Current opinion in otolaryngology & head and neck surgery.
[34] J. Qiu,et al. Complementary and Alternative Treatment for Allergic Conditions. , 2016 .
[35] J. Bernstein,et al. Combination Therapy in Allergic Rhinitis: What Works and What Does Not Work , 2016, American journal of rhinology & allergy.
[36] M. Mäkelä,et al. Factors affecting revision rate of chronic rhinosinusitis , 2016, Laryngoscope investigative otolaryngology.
[37] R. Schleimer,et al. Chronic Rhinosinusitis with Nasal Polyps. , 2016, The journal of allergy and clinical immunology. In practice.
[38] G. Scadding,et al. Saline irrigation for chronic rhinosinusitis. , 2016, The Cochrane database of systematic reviews.
[39] W. Fokkens,et al. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis , 2016, Expert opinion on pharmacotherapy.
[40] H. Esmaeilzadeh,et al. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial. , 2015, Clinical immunology.
[41] Helen K. Reddel,et al. A summary of the new GINA strategy: a roadmap to asthma control , 2015, European Respiratory Journal.
[42] W. Fokkens,et al. Capsaicin for non-allergic rhinitis. , 2015, The Cochrane database of systematic reviews.
[43] P. Donnan,et al. NSAID‐exacerbated respiratory disease: a meta‐analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity , 2015, Allergy.
[44] David King,et al. Saline nasal irrigation for acute upper respiratory tract infections. , 2015, The Cochrane database of systematic reviews.
[45] Andrew A. White,et al. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature. , 2015, The Journal of allergy and clinical immunology.
[46] H. Esmaeilzadeh,et al. Clinical and Immunological Effects of Aspirin Desensitization in Patients with Aspirin Exacerbated Respiratory Diseases; A Randomized, Double Blind, Placebo Controlled Trial , 2015 .
[47] S. Wenzel,et al. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. , 2015, The Journal of allergy and clinical immunology.
[48] E. Nizankowska-Mogilnicka,et al. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study. , 2014, The Journal of allergy and clinical immunology.
[49] G. Scadding,et al. Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease , 2014, The World Allergy Organization journal.
[50] P. Hellings,et al. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. , 2014, The Journal of allergy and clinical immunology.
[51] G. Scadding,et al. Topical nasal lysine aspirin in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis with nasal polyposis , 2014, Expert review of clinical immunology.
[52] J. Mullol,et al. Fluticasone Furoate Inhibits Cytokine Secretion from Nasal Epithelial Cells and Reduces Eosinophil Survival in an in vitro Model of Eosinophilic Inflammation , 2014, International Archives of Allergy and Immunology.
[53] G. Canonica,et al. Pharmacotherapy of allergic rhinitis: current options and future perspectives , 2014, Expert opinion on pharmacotherapy.
[54] E. Bleecker,et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.
[55] R. Salib,et al. A prospective randomised single‐blinded clinical trial comparing the efficacy and tolerability of the nasal douching products Sterimar™ and Sinus Rinse™ following functional endoscopic sinus surgery , 2013, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[56] A. Zwinderman,et al. Severe adult-onset asthma: A distinct phenotype. , 2013, The Journal of allergy and clinical immunology.
[57] G. Scadding,et al. Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease , 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[58] I. Schmidtmann,et al. Low‐dose aspirin desensitization in individuals with aspirin‐exacerbated respiratory disease , 2013, Allergy.
[59] Andrew A. White,et al. Aspirin desensitization in aspirin-exacerbated respiratory disease. , 2013, Immunology and allergy clinics of North America.
[60] J. Mullol,et al. Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin‐intolerant asthmatics , 2013, Respirology.
[61] L. Teran,et al. Aspirin-Intolerant Asthma: A Comprehensive Review of Biomarkers and Pathophysiology , 2013, Clinical Reviews in Allergy & Immunology.
[62] P. Filipe,et al. Mechanisms of Action of Topical Corticosteroids in Psoriasis , 2012, International journal of endocrinology.
[63] M. Hellmich,et al. Nasal irrigation as an adjunctive treatment in allergic rhinitis: A systematic review and meta-analysis , 2012, American journal of rhinology & allergy.
[64] S. Holgate,et al. Aspirin Exacerbated Respiratory Disease , 2012, Journal of allergy.
[65] S. Esposito,et al. Hypertonic Saline is More Effective Than Normal Saline in Seasonal Allergic Rhinitis in Children , 2012, International journal of immunopathology and pharmacology.
[66] F. Simons,et al. Histamine and H1-antihistamines: celebrating a century of progress. , 2011, The Journal of allergy and clinical immunology.
[67] J Bousquet,et al. Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study , 2011, Allergy.
[68] C. Bachert,et al. Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. , 2011, Rhinology.
[69] N. M. Kushnir. The role of decongestants, cromolyn, guafenesin, saline washes, capsaicin, leukotriene antagonists, and other treatments on rhinitis. , 2011, Immunology and allergy clinics of North America.
[70] M. Blaiss,et al. Management of Rhinitis: Allergic and Non-Allergic , 2011, Allergy, asthma & immunology research.
[71] L. Giacomelli,et al. Effects of sulfurous, salty, bromic, iodic thermal water nasal irrigations in nonallergic chronic rhinosinusitis: a prospective, randomized, double-blind, clinical, and cytological study. , 2011, American journal of otolaryngology.
[72] K. Chapman,et al. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights , 2011, Molecular and Cellular Endocrinology.
[73] E. Meltzer,et al. Overview of the treatment of allergic rhinitis and nonallergic rhinopathy. , 2011, Proceedings of the American Thoracic Society.
[74] R. Naclerio,et al. Anatomy and physiology of the upper airway. , 2011, Proceedings of the American Thoracic Society.
[75] D. Stevenson,et al. Aspirin-Exacerbated Respiratory Disease: Evaluation and Management , 2010, Allergy, asthma & immunology research.
[76] J. Bernstein,et al. Azelastine HCl: A Review of the Old and New Formulations , 2010 .
[77] Michael X. Cohen,et al. Oxytocin Enhances Amygdala-Dependent, Socially Reinforced Learning and Emotional Empathy in Humans , 2010, The Journal of Neuroscience.
[78] M. Kaliner,et al. Comprehensive review of olopatadine: the molecule and its clinical entities. , 2010, Allergy and asthma proceedings.
[79] M. Okano. Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis , 2009, Clinical and experimental immunology.
[80] L. Pignataro,et al. Nasal Lavage in Pregnant Women with Seasonal Allergic Rhinitis: A Randomized Study , 2009, International Archives of Allergy and Immunology.
[81] P. Keith,et al. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? , 2009, Current medical research and opinion.
[82] W. Berger. Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis , 2009 .
[83] A. Süslü,et al. Effects of buffered 2.3%, buffered 0.9%, and non-buffered 0.9% irrigation solutions on nasal mucosa after septoplasty , 2009, European Archives of Oto-Rhino-Laryngology.
[84] Xing Tang,et al. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[85] E. Meltzer,et al. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications , 2008, Allergy.
[86] F. Horak. Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis , 2008, Therapeutics and clinical risk management.
[87] T. Deutschle,et al. Long‐term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily , 2008, Allergy.
[88] R. Nathan,et al. Intranasal Mometasone Furoate Alleviates the Ocular Symptoms Associated with Seasonal Allergic Rhinitis: Results of a Post Hoc Analysis , 2008, International Archives of Allergy and Immunology.
[89] G. Viegi,et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.
[90] J. Skoupá,et al. Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. , 2008, Archives of otolaryngology--head & neck surgery.
[91] P. Roland,et al. An assessment of the onset and duration of action of olopatadine nasal spray , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[92] M. Ryan,et al. The effect of saline solutions on nasal patency and mucociliary clearance in rhinosinusitis patients , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[93] C. Janson,et al. Allergic rhinitis and onset of bronchial hyperresponsiveness: a population-based study. , 2007, American journal of respiratory and critical care medicine.
[94] C. Bachert,et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity , 2007, Allergy.
[95] G. Roomans,et al. Effects of hyperosmotic stress on cultured airway epithelial cells , 2007, Cell and Tissue Research.
[96] R. Garadi,et al. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate. , 2007, Allergy and asthma proceedings.
[97] J. Bernstein. Azelastine hydrochloride:a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability , 2007, Current medical research and opinion.
[98] G. Scadding,et al. Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma. , 2007, The Journal of laryngology and otology.
[99] P. Patel,et al. Onset of Action of Azelastine Nasal Spray Compared with Mometasone Nasal Spray and Placebo in Subjects with Seasonal Allergic Rhinitis Evaluated in an Environmental Exposure Chamber , 2007, American journal of rhinology.
[100] R. Simon,et al. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. , 2007, The Journal of allergy and clinical immunology.
[101] P. Barnes. How corticosteroids control inflammation: Quintiles Prize Lecture 2005 , 2006, British journal of pharmacology.
[102] D. Price,et al. ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. , 2006, The Journal of allergy and clinical immunology.
[103] U. Munzel,et al. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy , 2006, Current medical research and opinion.
[104] W. Berger,et al. Mometasone Furoate Improves Congestion in Patients with Moderate-to-Severe Seasonal Allergic Rhinitis , 2005, The Annals of pharmacotherapy.
[105] E. Bleecker,et al. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. , 2005, The Journal of allergy and clinical immunology.
[106] G. Scadding,et al. Intranasal Lysine‐Aspirin in Aspirin‐Sensitive Nasal Polyposis: A Controlled Trial , 2005, The Laryngoscope.
[107] G. Sambataro,et al. Nasal Rinsing with Hypertonic Solution: An Adjunctive Treatment for Pediatric Seasonal Allergic Rhinoconjunctivitis , 2005, International Archives of Allergy and Immunology.
[108] J. Bernstein,et al. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. , 2005, Clinical therapeutics.
[109] G. Scadding,et al. Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis. , 2005, The Journal of allergy and clinical immunology.
[110] K. Tano,et al. A Daily Nasal Spray with Saline Prevents Symptoms of Rhinitis , 2004, Acta oto-laryngologica.
[111] M. Ryan,et al. Effects of Buffered Saline Solution on Nasal Mucociliary Clearance and Nasal Airway Patency , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[112] F. Merkus,et al. Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[113] T. Craig,et al. Inflammatory Responses in Allergic Rhinitis: Traditional Approaches and Novel Treatment Strategies , 2004, The Journal of the American Osteopathic Association.
[114] K. Rickard,et al. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. , 2003, Allergy and asthma proceedings.
[115] S. Plontke,et al. Investigating the Nasal Cycle Using Endoscopy, Rhinoresistometry, and Acoustic Rhinometry , 2003, The Laryngoscope.
[116] G. Rettinger,et al. The relationship between water vapour saturation of inhaled air and nasal patency , 2003, European Respiratory Journal.
[117] M. Andersson,et al. Hypertonic saline increases secretory and exudative responsiveness of human nasal airway in vivo , 2003, European Respiratory Journal.
[118] M. Mundt,et al. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. , 2002, The Journal of family practice.
[119] G. Scadding,et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. , 2002, The New England journal of medicine.
[120] R. Simon,et al. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[121] G. Rodrigo,et al. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[122] S. Garg,et al. Permeability issues in nasal drug delivery. , 2002, Drug discovery today.
[123] A. Nagler,et al. Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood‐derived mast cells , 2002 .
[124] Q. Hamid,et al. Intrasinus Administration of Topical Budesonide to Allergic Patients With Chronic Rhinosinusitis Following Surgery , 2002, The Laryngoscope.
[125] R. Leurs,et al. H1‐antihistamines: inverse agonism, anti‐inflammatory actions and cardiac effects , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[126] M. Gillard,et al. Binding characteristics of cetirizine and levocetirizine to human H(1) histamine receptors: contribution of Lys(191) and Thr(194). , 2002, Molecular pharmacology.
[127] J. Bousquet,et al. Allergic rhinitis and its impact on asthma. , 2001, The Journal of allergy and clinical immunology.
[128] C. Caruso,et al. Measurement of Inflammatory Mediators of Mast Cells and Eosinophils in Native Nasal Lavage Fluid in Nasal Polyposis , 2001, International Archives of Allergy and Immunology.
[129] H. Hoogsteden,et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. , 2001, The Journal of allergy and clinical immunology.
[130] A. Ishii,et al. Effects of olopatadine hydrochloride on the release of thromboxane B2 and histamine from nasal mucosa after antigen–antibody reaction in guinea pigs , 2001 .
[131] G. Hommel,et al. Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease , 2000, European Archives of Oto-Rhino-Laryngology.
[132] G. Paludetti,et al. Effects of lysine-acetylsalicylate (LAS) treatment in nasal polyposis: two controlled long term prospective follow up studies , 2000, Thorax.
[133] P. Barnes,et al. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. , 2000, The Journal of allergy and clinical immunology.
[134] L. Klimek,et al. Aktuelle Aspekte der nasalen Glukokortikosteroidtherapie , 2000, HNO.
[135] J. Homer,et al. The effect of hypertonicity on nasal mucociliary clearance. , 2000, Clinical otolaryngology and allied sciences.
[136] C. Shim,et al. Prolonged delivery of nicotine in rats via nasal administration of proliposomes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[137] J Bousquet,et al. Consensus statement * on the treatment of allergic rhinitis , 2000, Allergy.
[138] H. Hoogsteden,et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. , 2000, American journal of respiratory and critical care medicine.
[139] R. Leurs,et al. Mutational Analysis of the Antagonist-binding Site of the Histamine H1 Receptor* , 1999, The Journal of Biological Chemistry.
[140] R. Schleimer,et al. An in vitro comparison of commonly used topical glucocorticoid preparations. , 1999, The Journal of allergy and clinical immunology.
[141] T. Craig,et al. Efficacy and safety of azelastine nasal spray for the treatment of allergic rhinitis , 1999, The Journal of the American Osteopathic Association.
[142] M. Carlston. A clinical trial of hypertonic saline nasal spray. , 1999, Archives of family medicine.
[143] R. Puy,et al. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials , 1998, BMJ.
[144] Nakahata,et al. The effects of anti‐asthma drugs on mediator release from cultured human mast cells , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[145] S. Matsuo,et al. Influence of the anti-allergic agent, azelastine, on tumor necrosis factor-alpha (TNF-alpha) secretion from cultured mouse mast cells. , 1998, In vivo.
[146] L. Mastalerz,et al. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. , 1998, The Journal of allergy and clinical immunology.
[147] D. Shoseyov,et al. Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. , 1998, The Journal of allergy and clinical immunology.
[148] R. Blake,et al. A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhinosinusitis. , 1998, Archives of family medicine.
[149] D. Tinkelman,et al. The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. , 1998, Allergy and asthma proceedings.
[150] M. Billah,et al. The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells. , 1997, The Journal of allergy and clinical immunology.
[151] S. Yamamoto,et al. Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. , 1997, Journal of immunology.
[152] David S. Parsons,et al. Mucociliary Clearance and Buffered Hypertonic Saline Solution , 1997, The Laryngoscope.
[153] M. Andersson,et al. Topical azelastine has a 12‐hour duration of action as assessed by histamine challenge‐induced exudation of α2‐macroglobulin into human nasal airways , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[154] R. Doty,et al. Influence of Age on the ‘Nasal Cycle’ , 1997, The Laryngoscope.
[155] R. Simon,et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. , 1996, The Journal of allergy and clinical immunology.
[156] B. Fisch,et al. Intranasal nafarelin versus buserelin (short protocol) for controlled ovarian hyperstimulation before in vitro fertilization: a prospective clinical trial. , 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[157] J. M. Cousin,et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.
[158] S. Yamamoto,et al. Inhibition of leukotriene synthesis by azelastine. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[159] S. Xu,et al. Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[160] G. Scadding,et al. Intranasal lysine aspirin in recurrent nasal polyposis. , 1995, Clinical otolaryngology and allied sciences.
[161] M. Johnson,et al. Fluticasone propionate--an update on preclinical and clinical experience. , 1995, Respiratory medicine.
[162] G. K. Scadding. Rhinitis medicamentosa , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[163] T. Yagi,et al. [Fluticasone propionate reduced the production of GM-CSF, IL-6 and IL-8 generated from cultured nasal epithelial cells]. , 1994, Arerugi = [Allergy].
[164] A. Sala,et al. Effects of loratadine on cytosolic Ca2+ levels and leukotriene release: novel mechanisms of action independent of the anti-histamine activity. , 1994, European journal of pharmacology.
[165] S. Gizurarson. The relevance of nasal physiology to the design of drug absorption studies , 1993 .
[166] E. Meltzer,et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. , 1992, The Journal of allergy and clinical immunology.
[167] Y. Sugimoto,et al. The effects of the serotonin1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rats. , 1992, Japanese journal of pharmacology.
[168] G. Papa,et al. Intranasal treatment with lysine acetylsalicylate in patients with nasal polyposis. , 1991, Annals of allergy.
[169] J. Kemp,et al. Comparison of intranasal cromolyn sodium, 4%, and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance, and rhinomanometry. , 1991, Annals of allergy.
[170] R. Sofia,et al. Inhibition of allergic and nonallergic leukotriene C4 formation and histamine secretion by azelastine: implication for its mechanism of action. , 1989, International archives of allergy and applied immunology.
[171] N. Johnson,et al. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. , 1988, Thorax.
[172] W. Wingert,et al. Medicated versus saline nose drops in the management of upper respiratory infection. , 1984, Helvetica paediatrica acta.
[173] P. Borum,et al. Intranasal ipratropium: a new treatment for perennial rhinitis. , 1979, Clinical otolaryngology and allied sciences.
[174] Alasdair Breckenridge,et al. Meyler's Side Effects of Drugs , 1976 .
[175] G. Storey,et al. Beclomethasone Dipropionate: A New Steroid Aerosol for the Treatment of Allergic Asthma , 1972, British medical journal.
[176] P. Norman. American academy of allergy 25th anniversary series: A rational approach to desensitization , 1969 .
[177] L. Gray. Deviated nasal septum. 3. Its influence on the physiology and disease of the nose and ear. I. , 1967, The Journal of laryngology and otology.
[178] R. Settipane,et al. Allergic rhinitis , 2005, Rhinology and Anterior Skull Base Surgery.
[179] H. Haas. [Histamine and antihistamines]. , 1951, Arzneimittel-Forschung.